Delivery Order 75N91019D00024-75N91026F00020
Award Date 9/21/26
Potential Completion Date 9/20/27
Potential Value $4.5M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 2, 2016, with a ceiling value of $18.5 million for Building 538, 1st Floor refurbishment and infrastructure at the Frederick National Laboratory for Cancer Research. Place of performance is Frederick, MD. The order carries a cost-no-fee pricing structure and an ultimate completion date of June 30, 2019. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 26, 2015, with a ceiling value of $7.66 million for Building 538 infrastructure project work at the Frederick National Laboratory for Cancer Research. The delivery order is priced on a cost-no-fee basis with an ultimate completion date of June 30, 2019. Place of performance is Frederick, Maryland. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 30, 2026, with a ceiling value of $1,912,753 for campus replacement of the Biomedical Specimen Computing System (BSCS) at Frederick National Laboratory for Cancer Research, with ultimate completion by October 25, 2028. The order is priced on a cost-plus-fixed-fee basis. Place of performance is Frederick, MD 21702. Leidos Biomedical Research operates the Frederick National Laboratory for Cancer...
- The National Cancer Institute issued a $2,034,923 delivery order to Leidos Biomedical Research Inc. on September 17, 2025, with an ultimate completion date of September 30, 2027, under a cost-plus-fixed-fee pricing structure. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor subsidiary of Leidos Holdings, Inc., providing biomedical research and facilities support services to the National Cancer Institute and National Institutes of Health....
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2020, with a ceiling value of $37.7 million for CPTAC biospecimen collection, with ultimate completion on August 30, 2027. Leidos Biomedical Research Inc. is an FFRDC contractor subsidiary of Leidos Holdings, Inc., serving as the National Cancer Institute's primary biomedical research support provider. Place of performance is Frederick, Maryland. The order is cost-plus-fixed-fee with no...
- The National Cancer Institute (NCI) awarded a delivery order valued at approximately $19.2 million to Leidos Biomedical Research Inc. on August 25, 2020, with an ultimate completion date of December 2, 2027. This cost-plus-fixed-fee contract is part of the FY20 Consolidated Facilities task order program and does not include a small business set-aside designation. The work will be performed at the Frederick National Laboratory for Cancer Research in Frederick, Maryland, where Leidos Biomedical...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 15, 2016, with a ceiling value of $4,527,878.03 for Building 433 North refurbishment and infrastructure work, with final funding modification (MOD 010) completing the order on September 6, 2019. Place of performance is Frederick, Maryland. The delivery order is priced on a cost-no-fee basis. Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., operates as a Federally Funded...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on April 14, 2026, with a ceiling value of $478,339 for chiller upgrade work at the Frederick National Laboratory for Cancer Research. Place of performance is Frederick, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of October 7, 2027. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor providing...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 18, 2017, with a ceiling value of $5.39 million for Building 469 first-floor refurbishment and infrastructure work on a cost-plus-fixed-fee basis. Place of performance is Frederick, Maryland. The ultimate completion date is May 17, 2019. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute and National...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 15, 2017, for refurbishment and infrastructure upgrades to Building 539, 1st Floor, Phase 1, with a ceiling value of $7.16 million under cost-plus-fixed-fee pricing. Place of performance is Frederick, MD. The ultimate completion date is September 30, 2020. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor serving the National Cancer...